Singapore Pneumonia is a type of lung infection caused by bacteria,
such as the Streptococcus pneumonia virus, fungi, and parasites. In pneumonia,
the air sacs of the lungs called alveoli are filled with fluid or pus that
causes inflammation. The Singapore symptoms of pneumonia include short breathing, fever,
chest pain, nausea & vomiting. However, these clinical symptoms overlap
with many other diseases, such as asthma, bronchitis, and the common cold,
making it difficult to diagnose pneumonia. Physicians recommend tests such as
blood tests, sputum tests, pleural fluid cultures, and pulse oximetry tests to
confirm the onset of pneumonia.
Download Sample
Report: https://www.alliedmarketresearch.com/request-sample/3776
This disease is most prevalent in South Asia and African countries. The key
factors that drive Pneumonia Testing Market Growth include an increase in
technological advancement in pneumonia testing systems, such as the development
of enhanced nucleic acid detection tests and advancement in point of care (POC)
tests.
Moreover, an increase in awareness toward early diagnosis
and a rise in government expenditures on healthcare fuel the market growth.
However, the limited detection capability & accuracy of some of the
pneumonia testing products and regulatory & economic hurdles hamper the
market growth. Conversely, the surge in the adoption of molecular diagnostic
testing and high untapped market potential in developing countries are
anticipated to provide lucrative growth opportunities for the market.
Singapore Pneumonia Testing Industry is segmented on the basis of
method, technology, type & end-user region. In terms of method, it is
classified into immunodiagnostics, molecular diagnostics, and point-of-care
(POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into
enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot,
polymerase chain reaction (PCR), immunohistochemistry (IHC), and others.
Depending on the end-user, it is classified into hospitals, diagnostic
laboratories, home care, and others. Region-wise, the Singapore market is analyzed across
North America, Europe, Asia-Pacific, and LAMEA.
Singapore POC testing segment was the major contributor to the
market in 2020, due to multiple benefits offered by this technique, such as
technological advancements, ease of use, and rapid results. The analyzers
segment is estimated to register the highest growth rate during the forecast
period, owing to t their frequent usage for pneumonia tests from 2020–to 2030.
Polymerase chain reaction registered the Singapore highest growth rate
in the forecast period among the different technologies, as this test can
identify the causative agent and accurately detect pneumonia in patients. Among
the end-user, the hospital occupied the major share of the pneumonia testing
market in 2021, due to a large number of patients suffering from pneumonia
across the world.
Region-wise Singapore Pneumonia Testing Market Analysis is done
across North America, Europe, Asia-Pacific, and LAMEA, in 2020, North America
accounted for the maximum Pneumonia Testing Market Share in 2020, owing to the
rise in prevalence of pneumonia and a surge in technological advancements in
various pneumonia testing products. However, Asia-Pacific is projected to grow
at the highest CAGR during the forecast period, owing to an increase in
investments by major companies in R&D activities.
Get Detail Report https://www.alliedmarketresearch.com/pneumonia-testing-market
.png)
0 Comments